Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies

This study has been terminated.
Sponsor:
Information provided by:
Sanofi
ClinicalTrials.gov Identifier:
NCT00113048
First received: June 3, 2005
Last updated: February 4, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given